Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • MEDICIS PHARMACEUTICAL CORP Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2008 FY2007 FY2006 FY2005 FY2004
    Assets
    Cash and Short Term Investments 343.88 M 794.68 M 554.26 M 742.53 M 634.04 M
    Net Receivables 52.59 M 22.20 M 71.66 M 46.70 M 47.86 M
    Total Inventories 24.23 M 29.97 M 27.02 M 19.08 M 19.54 M
    Progress Payments & Others -1.42 M -3.82 M -1.33 M -1.28 M -350,000.00
    Prepaid Expenses — — — — —
    Other Current Assets 72.84 M 27.24 M 33.42 M 24.98 M 32.42 M
    Current Assets Total 493.54 M 874.10 M 686.36 M 833.28 M 733.86 M
    Long Term Receivables 0.00 0.00 0.00 0.00 0.00
    Investment in Unconsolidated Subsidiaries 0.00 0.00 0.00 0.00 0.00
    Other Investments 55.33 M 17.07 M 130.29 M 0.00 0.00
    Property, Plant & Equipment Net 26.30 M 13.85 M 6.58 M 5.42 M 5.84 M
    Property, Plant & Equipment Gross 41.15 M 23.18 M 14.53 M 12.06 M 9.29 M
    Accumulated Depreciation 14.85 M 9.33 M 7.96 M 6.64 M 3.44 M
    Other Assets 321.12 M 248.82 M 234.13 M 307.26 M 338.68 M
    Deferred Charges 0.00 700,000.00 0.00 4.32 M 7.54 M
    Tangible Other Assets 2.92 M 11.92 M 2.18 M 8.58 M 8,000.00
    Intangible Other Assets 318.19 M 236.19 M 231.95 M 302.93 M 331.14 M
    Total Assets 896.28 M 1.15 B 1.06 B 1.15 B 1.08 B
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 0.00 283.91 M 169.16 M 27.41 M 17.89 M
    Accrued Payroll 15.32 M 13.48 M 6.51 M 8.07 M 6.05 M
    Income Taxes Payable 7.73 M 12.65 M 31.52 M 712,000.00 481,000.00
    Dividends Payable 0.00 0.00 0.00 1.60 M 1.40 M
    Other Current Liabilities 146.87 M 109.27 M 120.49 M 16.09 M 25.14 M
    Current Liabilities Total 185.90 M 451.13 M 363.29 M 140.83 M 67.12 M
    Long Term Debt 169.33 M 169.14 M 283.91 M 453.06 M 453.07 M
    Provision for Risks & Charges 0.00 0.00 0.00 0.00 0.00
    Deferred Taxes -77.15 M -59.58 M -65.37 M 8.57 M 2.89 M
    Deferred Income 4.17 M 6.67 M 0.00 0.00 0.00
    Deferred Tax Liability in Untaxed Reserves — — — — —
    Other Liabilities 10.35 M 3.17 M 0.00 0.00 0.00
    Total Liabilities 292.59 M 570.53 M 581.83 M 602.47 M 523.08 M
    Shareholders Equity
    Non-Equity Reserves 0.00 0.00 0.00 0.00 0.00
    Minority Interest 0.00 0.00 0.00 0.00 0.00
    Preferred Stock 0.00 0.00 0.00 0.00 0.00
    Common Equity 603.69 M 583.30 M 475.52 M 543.49 M 555.30 M
    Common Stock 969,000.00 965,000.00 952,000.00 938,000.00 926,000.00
    Capital Surplus 661.70 M 641.91 M 598.44 M 550.01 M 517.47 M
    Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
    Other Appropriated Reserves 537,000.00 379,000.00 -2.23 M 673,000.00 -1.30 M
    Unappropriated (Free) Reserves 0.00 0.00 0.00 0.00 0.00
    Retained Earnings 282.28 M 281.22 M 218.39 M 334.89 M 230.05 M
    Equity in Untaxed Reserves — — — — —
    ESOP Guarantees 0.00 0.00 0.00 0.00 0.00
    Unrealized Foreign Exchange Gain (Loss) 1.30 M 1.50 M — — —
    Unrealized Gain (Loss) on Marketable Securities 806,000.00 721,000.00 — — —
    Treasury Stock 343.37 M 343.01 M 342.80 M 342.73 M 190.91 M
    Total Liabilities & Shareholders Equity 896.28 M 1.15 B 1.06 B 1.15 B 1.08 B
    Common Shares Outstanding 56.72 M 56.35 M 55.39 M 54.40 M 57.50 M